MultiPark: Multidisciplinary research focused on Parkinson´s disease
2351 – 2360 of 3881
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer's Disease?
(
- Contribution to journal › Article
-
Mark
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
(
- Contribution to journal › Article
-
Mark
Systems level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
An ex Vivo Model for Evaluating Blood-Brain Barrier Permeability, Efflux, and Drug Metabolism.
(
- Contribution to journal › Article
-
Mark
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Dynamic susceptibility contrast perfusion MRI using phase-based venous output functions: : comparison with pseudo-continuous arterial spin labelling and assessment of contrast agent concentration in large veins.
(
- Contribution to journal › Article
-
Mark
Early- versus Late-Onset Alzheimer’s Disease—Differences in Functional Impairment.
2016) 9th Clinical Trials Conference on Alzheimer’s Disease(
- Contribution to conference › Poster
-
Mark
Plug and Play Brain : Understanding Integration of Transplanted Neurons for Brain Repair
(
- Contribution to journal › Article
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
(
- Contribution to journal › Article